COO and First Employee of Editas Medicine to Exit, Effective March 31

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-personnel-leaving.jpg" NAME"COO and First Employee of Editas Medicine to Exit, Effective March 31" ALT"COO and First Employee of Editas Medicine to Exit, Effective March 31"March 6, 2017By Mark Terry,…

Continue ReadingCOO and First Employee of Editas Medicine to Exit, Effective March 31

Following Up on Bristol-Myers Squibb's Restructuring Plans, Company Makes Move to Shift 1,250 Workers Out of Hopewell Township Site

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-bristol-myers-squibb.jpg" NAME"Following Up on Bristol-Myers Squibb's Restructuring Plans, Company to Shift 1,250 Workers Out of N.J. Site" ALT"Following Up on Bristol-Myers Squibb's Restructuring Plans, Company to Shift 1,250 Workers…

Continue ReadingFollowing Up on Bristol-Myers Squibb's Restructuring Plans, Company Makes Move to Shift 1,250 Workers Out of Hopewell Township Site

Chinese Billionaire's Biotech Hutchison China MediTech (Chi-Med) Shows Off Phase III Cancer Drug Data

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-research.jpg" NAME"Chinese Billionaire's Biotech Hutchison China MediTech Shows Off Phase III Cancer Drug Data" ALT"Chinese Billionaire's Biotech Hutchison China MediTech Shows Off Phase III Cancer Drug Data"March 3, 2017By…

Continue ReadingChinese Billionaire's Biotech Hutchison China MediTech (Chi-Med) Shows Off Phase III Cancer Drug Data

Sanofi Pasteur Inks $645 Million RSV Deal With AstraZeneca PLC's MedImmune

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-deal3.jpg" NAME"Sanofi Pasteur Inks $645 Million RSV Deal With AstraZeneca PLC's MedImmune" ALT"Sanofi Pasteur Inks $645 Million RSV Deal With AstraZeneca PLC's MedImmune"March 3, 2017By Mark Terry, BioSpace.com Breaking...…

Continue ReadingSanofi Pasteur Inks $645 Million RSV Deal With AstraZeneca PLC's MedImmune